Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Forest Labs sets to launch Daliresp in US
Daliresp is a selective PDE4 inhibitor, indicated as a treatment for reducing the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with
Daliresp is a selective PDE4 inhibitor, indicated as a treatment for reducing the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with
Validus pharmaceutical had been using a CRM system that ran on PDAs and could not report on all sales activity data. The screens on the PDA devices previously
The company is currently reviewing IRB’s request and expects to submit a revised Phase 2 clinical trial protocol to the board later this month. AVI BioPharma president and
Amylin recently filed litigation involving the two companies’ diabetes collaboration agreement. Lilly senior vice president and general counsel Robert Armitage said they have complied with their contractual obligations
Matrix M is an immune stimulating substance for use in vaccines, antibody production and immunological research. Matrix M was already licensed to Crucell for use in influenza vaccines,
The changes to the label for simvastatin-containing medications are based on the FDA’s review of the results of the seven-year Study of the Effectiveness of Additional Reductions in
APC-100 is an orally available drug and has demonstrated multiple activities in various model systems. Adamis Pharmaceuticals intends to commence APC-100 Phase 1/2a trials in patients who are
Pollinex Quattro is a four injection therapeutic vaccine which is being developed for the treatment of allergic conditions which offers same season relief in as little as three
MORAb-004 is a humanized monoclonal antibody to endosialin/tumor endothelial marker-1 (TEM-1), which is a protein that is expressed in many human malignancies, and which plays a role in
Omnia offers translational medicine services in the areas of process development, assay development, GMP manufacture and fill-finish for preclinical and clinical programs for therapeutics that do not have